Centre Leon Berard

This early-phase study tested a radioactive drug (177Lu-PSMA-1) in 6 adults with metastatic clear cell kidney cancer that had progressed after at least two prior treatments. The goal was to check safety and see if the drug could control the disease for 24 weeks. The treatment was…

This study tested a combination of two drugs, atezolizumab and bevacizumab, in 33 adults with advanced head and neck cancer that had already been treated with platinum-based chemotherapy. The goal was to see if the combo could shrink or control tumors. The approach aims to boost …

This study tested a combination of two drugs (atezolizumab and cobimetinib) in children and adults with advanced soft tissue sarcoma that has spread. The goal was to see if the treatment could stop or shrink tumors. About 229 people took part, and researchers measured how many ha…

This study looked at whether a 6-month physical activity program using a fitness tracker could help women with metastatic breast cancer feel better and have less fatigue. 124 women were randomly assigned to either get activity recommendations plus a tracker and walking sessions, …

This study looked back at medical records of 207 adults who died from sarcoma to understand how they were cared for by palliative teams. Researchers tracked things like hospital stays in palliative care units, visits with palliative doctors, and use of chemotherapy in the final w…

This study analyzed tumor and blood samples from 84 patients with brain cancer, meningioma, or sarcoma to find biomarkers that predict how well proton beam therapy works. The goal is to identify genetic or immune markers linked to tumor shrinkage six months after treatment. This …